Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

17 Feb 2022 14:55

RNS Number : 0473C
B.P. Marsh & Partners PLC
17 February 2022
 

Date: 17th February 2022

 

B.P. Marsh & Partners Plc

PDMR and Director Dealings

 

B.P. Marsh (AIM: BPM), the specialist investor in early-stage financial services businesses, announces that it has been notified that Mr. Daniel Topping, Chief Investment Officer, has traded in the ordinary shares of 10 pence each in the Company ("Ordinary Shares").

 

The Company has been made aware that Mr. Topping on 16th February 2022 purchased 1,488 Ordinary Shares for 324.89p per share, or an aggregate of £4,834.36. As a result of the transaction, Daniel has a beneficial interest in 122,369 Ordinary Shares (including 11,434 shares owned by his wife Claire Cronin), together with a beneficial interest in 18,660 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.38% of the total voting rights of the Company.

 

Additionally, Daniel, as part of the Company's Joint Share Ownership Plan, has a beneficial interest (as a joint owner alongside JTC Employer Solutions Trustee) over 167,465 Ordinary Shares, representing approximately 0.45% of the total voting rights of the Company.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

 

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via SIPP

c)

Price(s) and volumes(s)

 

Price(s)

£3.25

Volume(s)

1,488

 

 

 

d)

Aggregated information

N/A

e)

Date of the transaction

22-02-16

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

 

+44 (0)20 7233 3112

 

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

 

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa Macmaster

 

Financial PR/Investor Relations

Tavistock

Simon Hudson / Tim Pearson

+44 (0)20 7886 2500

 

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

 

Notes to Editors:

About B.P. Marsh & Partners Plc

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Several of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDDXUBDGDR
Date   Source Headline
24th Feb 20257:00 amRNSTrading Statement
14th Feb 20252:58 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSInterim Dividend Declaration
8th Jan 202510:20 amRNSDirector/PDMR Shareholding
6th Jan 202512:00 pmRNSDirector/PDMR Shareholding
12th Dec 20243:18 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSFollow on Investment – XPT Group LLC
12th Nov 20249:36 amRNSDirector/PDMR Shareholding
31st Oct 20245:45 pmRNSCancellation of Shares & Buy-Back Programme Update
30th Oct 20247:00 amRNSNew Investment – SRT & Partners Limited
29th Oct 202412:40 pmRNSFollow on Investment – Pantheon Specialty Group
29th Oct 20249:40 amRNSSale of Lilley Plummer Holdings Limited
23rd Oct 20247:00 amRNSHalf Year Results
14th Oct 20247:00 amRNSNew Investment – Volt UW HoldCo Ltd
11th Oct 202410:10 amRNSTransaction in Own Shares
9th Oct 202410:00 amRNSNotice of HY Results and Investor Presentation
7th Oct 20244:03 pmRNSTransaction in Own Shares
1st Oct 20243:37 pmRNSTransaction in Own Shares
1st Oct 202411:04 amRNSTransaction in Own Shares
30th Sep 20242:20 pmRNSNew Investment – CEE Specialty s.r.o.
30th Sep 20249:00 amRNSTransaction in Own Shares
27th Sep 20241:10 pmRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 202412:05 pmRNSTransaction in Own Shares
19th Sep 20245:02 pmRNSTransaction in Own Shares
18th Sep 20243:15 pmRNSTransaction in Own Shares
18th Sep 20243:00 pmRNSDirector/PDMR Shareholding
17th Sep 20245:00 pmRNSTransaction in Own Shares
17th Sep 20247:02 amRNSTransaction in Own Shares
17th Sep 20247:01 amRNSAppointment of Joint Corporate Broker
17th Sep 20247:00 amRNSTrading Statement
16th Sep 20242:15 pmRNSDirectorate Change
13th Sep 20243:04 pmRNSTransaction in Own Shares
10th Sep 20241:43 pmRNSTransaction in Own Shares
5th Sep 20242:00 pmRNSDirectorate Change
5th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20245:05 pmRNSTransaction in Own Shares
2nd Sep 202410:09 amRNSTransaction in Own Shares
27th Aug 20243:15 pmRNSTransaction in Own Shares
13th Aug 20249:33 amRNSTransaction in Own Shares
6th Aug 20244:25 pmRNSTransaction in Own Shares
5th Aug 20242:03 pmRNSTransaction in Own Shares
5th Aug 20249:20 amRNSDirector/PDMR Shareholding
2nd Aug 20248:45 amRNSShare Buy-Back Programme Update
23rd Jul 20242:35 pmRNSResult of AGM
19th Jul 20242:32 pmRNSTransaction in Own Shares
18th Jul 202411:19 amRNSTransaction in Own Shares
16th Jul 20243:20 pmRNSTransaction in Own Shares
12th Jul 20248:35 amRNSTransaction in Own Shares
10th Jul 20242:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.